Noam Sahbti

Committed to improving the way clinical trials are managed, making them more efficient and effective to drive more drugs to the market faster, RXE2 is focused on leveraging the power of community, and specifically community pharmacists, providing them with powerful and cutting-edge technology, so that they can help the pharmaceuticals with their challenges in clinical trials. Clinical studies traditionally take many years and cost hundreds of millions of dollars to design, run and analyze. The biggest challenges pharmaceutical companies face when it comes to clinical trials and research are usually patient recruitment (both in time and diversity), patient engagement and retention (patient adherence to the protocol, dropout rates) and the logistics of drug dispensing and counseling. RXE2 taps into its vast network of community pharmacists and leverages their expertise, knowledge of their communities and patients and the trust they enjoy by their patients to help the pharmaceuticals resolve these challenges. We do all this with powerful AI, Machine Learning and other cutting-edge technologies.

NanoHive Medical (formerly HD LifeSciences) created the proprietary, biomimetic Soft Titanium technology, which clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides surgeons and their patients with the ideal features that lead to consistently strong fusion constructs and efficacious clinical experiences.

nQ Medical's artificial intelligence technology has shown in four years of clinical trials at MIT to substantially change the way disease is managed for a wide range of neuromotor and neurocognitive disorders. nQ focuses on analysis of user interaction with common electronic devices to capture functional decline related to neurodegenerative disorders. The fine control of typing and touch screen kinematics together with the frequent use of electronic devices allows for precise monitoring of small changes in neurodegeneration that frequently go unnoticed by clinicians. It also allows for 24/7, passive, data collection, thus eliminating the adherence problems plaguing most therapeutic interventions. We support clinical trials with remote, online recruitment of ideal study participants - Disease detection/Shortened recruitment time - Better disease staging/Patient targeting - Less in-clinic observation (at-home, unbiased real world data) - Passive/continuous monitoring yields earliest measure of therapeutic impact and helps shape treatment pathways for neurodegenerative diseases Compounds coming out of trials can also be supported with our Mobile PD Management Platform: - Rx, remote disease progression and therapy measurement tool used with outpatient treatment under the care of health care professional, in conjunction with drug/device - Digital health device supporting medication-assisted treatment: - Clinical titration decisions - Patient engagement and adherence tool/Caregiver observation tool - Direct download to patient’s mobile device after prescription. Intended to be used in conjunction with a clinician-supervised outpatient treatment protocol.

A Boston-based investment group that provides seed funding to early-stage life science and healthcare companies.The Sky Ventures Group brings diverse classes of prestigious investors together including top-tier corporate venture capital, foundations, family offices and individual angel investors who want to change the early stage investment landscape and impact lives by building outstanding life science & healthcare companies.

XRHealth is a leading provider of immersive healthcare solutions, leveraging the power of XR (extended reality, encompassing both virtual and augmented reality) to revolutionize patient care and rehabilitation. Founded to enhance the effectiveness of medical treatments and improve patient outcomes, XRHealth develops cutting-edge XR platforms that offer innovative therapeutic experiences. These platforms are designed for various medical applications, including physical therapy, cognitive rehabilitation, pain management, and mental health support. In addition to developing state-of-the-art technology, XRHealth operates its clinics, providing direct access to its immersive therapies. Furthermore, the company sells its products to healthcare organizations worldwide, enabling hospitals, clinics, and rehabilitation centers to integrate XR into their treatment protocols. The recent merger with Amelia Virtual Care has expanded XRHealths capabilities, adding more mental health expertise and applications to its platform. This merger enhances their offerings in mental health support, providing even more comprehensive care for patients. By integrating advanced technology with clinical expertise, XRHealth delivers personalized and engaging treatments that empower patients and healthcare professionals. Committed to transforming the future of healthcare, XRHealth stands at the forefront of the digital health revolution. Connect with us to receive a demo!🥽

Committed to improving the way clinical trials are managed, making them more efficient and effective to drive more drugs to the market faster, RXE2 is focused on leveraging the power of community, and specifically community pharmacists, providing them with powerful and cutting-edge technology, so that they can help the pharmaceuticals with their challenges in clinical trials. Clinical studies traditionally take many years and cost hundreds of millions of dollars to design, run and analyze. The biggest challenges pharmaceutical companies face when it comes to clinical trials and research are usually patient recruitment (both in time and diversity), patient engagement and retention (patient adherence to the protocol, dropout rates) and the logistics of drug dispensing and counseling. RXE2 taps into its vast network of community pharmacists and leverages their expertise, knowledge of their communities and patients and the trust they enjoy by their patients to help the pharmaceuticals resolve these challenges. We do all this with powerful AI, Machine Learning and other cutting-edge technologies.

NanoHive Medical (formerly HD LifeSciences) created the proprietary, biomimetic Soft Titanium technology, which clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides surgeons and their patients with the ideal features that lead to consistently strong fusion constructs and efficacious clinical experiences.

nQ Medical's artificial intelligence technology has shown in four years of clinical trials at MIT to substantially change the way disease is managed for a wide range of neuromotor and neurocognitive disorders. nQ focuses on analysis of user interaction with common electronic devices to capture functional decline related to neurodegenerative disorders. The fine control of typing and touch screen kinematics together with the frequent use of electronic devices allows for precise monitoring of small changes in neurodegeneration that frequently go unnoticed by clinicians. It also allows for 24/7, passive, data collection, thus eliminating the adherence problems plaguing most therapeutic interventions. We support clinical trials with remote, online recruitment of ideal study participants - Disease detection/Shortened recruitment time - Better disease staging/Patient targeting - Less in-clinic observation (at-home, unbiased real world data) - Passive/continuous monitoring yields earliest measure of therapeutic impact and helps shape treatment pathways for neurodegenerative diseases Compounds coming out of trials can also be supported with our Mobile PD Management Platform: - Rx, remote disease progression and therapy measurement tool used with outpatient treatment under the care of health care professional, in conjunction with drug/device - Digital health device supporting medication-assisted treatment: - Clinical titration decisions - Patient engagement and adherence tool/Caregiver observation tool - Direct download to patient’s mobile device after prescription. Intended to be used in conjunction with a clinician-supervised outpatient treatment protocol.

A Boston-based investment group that provides seed funding to early-stage life science and healthcare companies.The Sky Ventures Group brings diverse classes of prestigious investors together including top-tier corporate venture capital, foundations, family offices and individual angel investors who want to change the early stage investment landscape and impact lives by building outstanding life science & healthcare companies.

XRHealth is a leading provider of immersive healthcare solutions, leveraging the power of XR (extended reality, encompassing both virtual and augmented reality) to revolutionize patient care and rehabilitation. Founded to enhance the effectiveness of medical treatments and improve patient outcomes, XRHealth develops cutting-edge XR platforms that offer innovative therapeutic experiences. These platforms are designed for various medical applications, including physical therapy, cognitive rehabilitation, pain management, and mental health support. In addition to developing state-of-the-art technology, XRHealth operates its clinics, providing direct access to its immersive therapies. Furthermore, the company sells its products to healthcare organizations worldwide, enabling hospitals, clinics, and rehabilitation centers to integrate XR into their treatment protocols. The recent merger with Amelia Virtual Care has expanded XRHealths capabilities, adding more mental health expertise and applications to its platform. This merger enhances their offerings in mental health support, providing even more comprehensive care for patients. By integrating advanced technology with clinical expertise, XRHealth delivers personalized and engaging treatments that empower patients and healthcare professionals. Committed to transforming the future of healthcare, XRHealth stands at the forefront of the digital health revolution. Connect with us to receive a demo!🥽